# Shanghai Jiao Tong University **Entity class:** University **Domain:** Biomedical Engineering / Academic Publishing **Doc Type:** Institution Node **Maturity:** Developed **Collection:** [[collections/Neurotech|Neurotech]] **Primary Sources:** [[wiki/Med-X|Med-X]] ## Definition **Shanghai Jiao Tong University is the Chinese research university that owns and publishes [[wiki/Med-X|Med-X]], the open-access biomedical-engineering journal, in partnership with Springer Nature.** Med-X launched in 2023 under editor-in-chief Lisa X. Xu, with Song Li as co-editor-in-chief and executive editors-in-chief Jun Chen, Brian Fowlkes, Shanbao Tong and Jian Ye. The journal holds 93 articles as of 23 October 2026 and carries the corpus's only peer-reviewed, disability-adjusted-life-year-weighted ranking of brain-computer-interface indications. ## Position in the corpus Med-X places Chinese academic capital adjacent to European publishing capital on the translation of brain-computer interfaces, which is a publisher graph the corpus had not previously recorded. The journal's open *Advances in Brain-Machine Interface* collection, with a deadline of 18 December 2026, is an active solicitation window for implant-adjacent researchers, and the register treats such collections as instruments of academic capital routing. Shanghai itself counts 60 innovative brain-computer-interface enterprises, three of whose invasive products entered the [[wiki/National Medical Products Administration|NMPA]] special review procedure for innovative devices. ## Open Questions - The university's own neurotechnology laboratories and their relation to the Shanghai company cluster. - Whether Med-X's brain-interface collection produces a distinct SJTU publication lineage. ## Research Inferences These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. Proposed IDs above INF-0500 come from the 2026-10-23 cycle: [[research/Research Inferences Integration Report - 2026-10-23|Research Inferences Integration Report — 2026-10-23]] · [[research/Research Inferences Integration Audit - 2026-10-23|Research Inferences Integration Audit — 2026-10-23]]. - **INF-0463 — Established.** Capability concentrates geographically because people, capital, and institutions co-locate and recruit locally. Cluster maps predict where a capability will mature, and the neurotechnology clusters are identifiable by trial-site distribution. - **INF-0465 — Strongly indicated.** Substantial neural-interface and brain-mapping programs operate outside the American reporting environment, with their own trials, companies, and standards participation. Visibility in English-language press is not a measure of capability, and native-language sourcing is required for an accurate picture. - **INF-0459 — Analytic.** Appointing an academic leader into a company transfers a laboratory's methods, students, and collaborations along with the individual. Senior appointments are therefore the highest-bandwidth technology-transfer events available and should be read as such. - **INF-0472 — Analytic.** Open publication and open tooling accelerate diffusion but reduce appropriability, which is why capabilities near commercialization close. Watching when a subfield stops publishing is a reliable indicator that it has become valuable. ## Relationships - **publishes:** [[wiki/Med-X|Med-X]], with Springer Nature. - **journal_output:** [[wiki/Med-X BCI-2035 Perspective|Med-X BCI-2035 Perspective]] (9 October 2026). - **national_context:** [[wiki/China BCI Industry Implementation Opinions|China BCI Industry Implementation Opinions]] · [[wiki/China Brain Project|China Brain Project]]. - **academic_peers_in_corpus:** [[wiki/Tsinghua University|Tsinghua University]] (co-developer of [[wiki/Neuracle|Neuracle]]'s NEO). - **regional_cluster:** [[wiki/NeuroXess|NeuroXess]] and the Shanghai enterprise cluster. - **ecosystem:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] · [[collections/Neurotech|Neurotech]]. ## Sources - [Med-X journal home — Springer Nature Link](https://link.springer.com/journal/44258) - [China grants world's first market approval for invasive BCI product — Xinhua, 14 March 2026](https://english.news.cn/20260314/fab8a8e69f004c74a6b40e2d6ae5bc54/c.html) (Shanghai enterprise and special-review figures) As of 23 October 2026.